Loading...
XSHE300981
Market cap636mUSD
Jan 10, Last price  
12.01CNY
1D
-2.99%
1Q
-3.77%
IPO
-77.98%
Name

Zhonghong Pulin Medical Products Co Ltd

Chart & Performance

D1W1MN
XSHE:300981 chart
P/E
—
P/S
2.22
EPS
—
Div Yield, %
6.31%
Shrs. gr., 5y
25.04%
Rev. gr., 5y
16.82%
Revenues
2.11b
+33.87%
550,611,138585,048,800604,083,100710,080,600951,153,298967,534,1271,170,814,0404,778,406,8724,909,310,9361,572,568,5132,105,249,607
Net income
-131m
L
3,035,80724,917,20042,313,40038,214,70065,010,53556,669,36289,266,0182,663,518,7162,341,903,87966,916,009-130,870,579
CFO
141m
+31.83%
13,365,927133,333,00092,230,044102,368,25296,027,72223,766,227184,382,5612,719,677,0592,362,497,606106,707,621140,676,906
Dividend
Jun 27, 20240.5 CNY/sh
Earnings
May 16, 2025

Profile

Zhonghong Pulin Medical Products Co., Ltd. researches, develops, manufactures, and sells plastic gloves. Its products include disposable vinyl and nitrile gloves for use in the medical, food service, and electronic industries. The company was founded in 2010 and is based in Tangshan, China. Zhonghong Pulin Medical Products Co., Ltd. operates as a subsidiary of Zhonghong Pulin Group Co., Ltd.
URL
https://www.zhonghongmedical.com/
IPO date
Apr 27, 2021
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
2,105,250
33.87%
1,572,569
-67.97%
Cost of revenue
2,174,557
1,507,022
Unusual Expense (Income)
NOPBT
(69,307)
65,546
NOPBT Margin
4.17%
Operating Taxes
(10,003)
Tax Rate
NOPAT
(59,304)
65,546
Net income
(130,871)
-295.57%
66,916
-97.14%
Dividends
(294,640)
(500,010)
Dividend yield
4.78%
8.87%
Proceeds from repurchase of equity
(8,957)
BB yield
0.15%
Debt
Debt current
153,545
57,007
Long-term debt
345,868
20,251
Deferred revenue
17,578
20,555
Other long-term liabilities
18,803
3,676
Net debt
(2,913,815)
(2,949,635)
Cash flow
Cash from operating activities
140,677
106,708
CAPEX
(103,064)
Cash from investing activities
205,517
(75,214)
Cash from financing activities
39,993
FCF
(6,286)
(590,408)
Balance
Cash
2,934,938
3,026,894
Long term investments
478,290
Excess cash
3,307,966
2,948,266
Stockholders' equity
4,105,041
4,326,736
Invested Capital
3,117,988
3,268,044
ROIC
2.31%
ROCE
1.05%
EV
Common stock shares outstanding
384,913
390,008
Price
16.02
10.89%
14.45
-57.71%
Market cap
6,166,314
9.45%
5,634,112
-57.71%
EV
3,399,434
2,697,681
EBITDA
137,236
213,411
EV/EBITDA
24.77
12.64
Interest
15,354
1,662
Interest/NOPBT
2.54%